IXICO plc PHYOF
0.77 USD +0.70 (+1,000.00%)
At closeFeb 5, 2026, 4:00 PM EST
0.15 Day range 0.15
0.07 52-week range 0.15
- YTD
- +1,000.00%
- 1 year
- +1,000.00%
News
proactiveinvestors.com IXICO shares jump 19% as revenue growth and order book strengthen IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the medical imaging and data analytics provider focused on central nervous system conditions, rose over 19% to 9.25p on Tuesday morning after forecasting 28%…
proactiveinvestors.com IXICO expects 28% revenue growth as orders accelerate IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and biomarker analytics company, expects annual revenue to rise 28% to £8.3 million, exceeding its upgraded guidance after an…
proactiveinvestors.com IXICO presents Parkinson's research showing improved brain imaging contrast Neuroscience imaging company IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) has presented new research at a European conference this week showing one MRI technique provides better contrast than another…
proactiveinvestors.com IXICO guidance unchanged after Huntington's cancellations IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), a neuroscience imaging and biomarker analytics company, has confirmed its revenue guidance remains unchanged after...
proactiveinvestors.co.uk IXICO guidance unchanged after Huntington's cancellations IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), a neuroscience imaging and biomarker analytics company, has confirmed its revenue guidance remains unchanged after two clients discontinued Huntington's…
proactiveinvestors.com South32’s $4.7bn Hermosa project clears key US approval as critical minerals push accelerates South32 Ltd (LSE:S32, ASX:S32, FRA:32Z, OTC:SHTLF, JSE:S32) has secured a major US federal approval for its US$4.7 billion Hermosa critical minerals project...
proactiveinvestors.com IXICO lifts revenue forecast on contract wins and wider client base - UPDATE Shares in IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging company, rose 11% to 9p after it has raised its revenue forecast for the...
proactiveinvestors.co.uk IXICO lifts revenue forecast on contract wins and wider client base IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging company, has raised its revenue forecast for the current financial year after stronger-than-expected trading. The company now…
proactiveinvestors.com SpaceX stock surges in hotly anticipated market debut SpaceX (NASDAQ:SPCX)’s closely watched public debut is off to a flying start. The stock, trading under $SPCX, opened at $150 after pricing its IPO at $135 —...
proactiveinvestors.co.uk IXICO expands scientific network in Alzheimer's and Parkinson's disease IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) has expanded its scientific network in Alzheimer's and Parkinson's disease, adding three senior specialists to its advisory board and launching new…
proactiveinvestors.com Percheron Therapeutics secures proposed WHO drug name for HMBD-002 cancer therapy Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has secured a proposed international nonproprietary name (pINN) from the World Health Organization for its...
proactiveinvestors.com Walmart price target lowered by UBS as Q1 results miss elevated expectations Walmart Inc (NYSE:WMT, XETRA:WMT) had its price target lowered by UBS to $141 from $147 following the company’s first-quarter results, while the broker said...
proactiveinvestors.com Bram Goorden discusses IXICO growth plans - ICYMI IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) CEO, Bram Goorden, talked with Proactive about the company’s interim results, highlighting strong revenue growth,...
proactiveinvestors.co.uk Bram Goorden discusses IXICO growth plans - ICYMI IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) CEO, Bram Goorden, talked with Proactive about the company's interim results, highlighting strong revenue growth, expanding demand in Alzheimer's disease…
seekingalpha.com IXICO plc (PHYOF) Q2 2026 Earnings Call Transcript IXICO plc (PHYOF) Q2 2026 Earnings Call Transcript
proactiveinvestors.com Zscaler set to benefit from federal tailwinds boosting fourth quarter outlook: analysts Zscaler Inc. (NASDAQ:ZS) is expected to deliver a strong fiscal third quarter when it reports results on May 26, with Jefferies analysts saying the...
proactiveinvestors.co.uk IXICO contract wins provide near-total revenue visibility for current year IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and analytics group, has secured £1.3 million of new contract work that its broker says should take the company's order book close…
proactiveinvestors.co.uk IXICO wins £1.3 million in Alzheimer's and Huntington's contracts IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and analytics group, has secured a contract win and a contract extension worth a combined £1.3 million over two years. The…
proactiveinvestors.com UK utility investors face prolonged uncertainty after worst sell-off since privatisation era UK utility shares face a potentially extended period of political and financial pressure after suffering their fourth-largest single-day decline since...
proactiveinvestors.com Cavendish sees IXICO forecasts as conservative after order book hits five-year high Shares in IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging and biomarker analytics specialist, rose as much as 11% after interim results...